1 AQLQ final scores at 12 months of follow‐up |
3 |
429 |
Mean Difference (IV, Random, 95% CI) |
0.28 [0.07, 0.50] |
1.1 Bronchial thermoplasty versus medical management |
2 |
141 |
Mean Difference (IV, Random, 95% CI) |
0.44 [0.10, 0.79] |
1.2 Bronchial thermoplasty versus sham bronchoscopies |
1 |
288 |
Mean Difference (IV, Random, 95% CI) |
0.18 [‐0.09, 0.45] |
2 ACQ final scores at 12 months of follow‐up |
3 |
429 |
Mean Difference (IV, Random, 95% CI) |
‐0.15 [‐0.40, 0.10] |
2.1 Bronchial thermoplasty versus medical management |
2 |
141 |
Mean Difference (IV, Random, 95% CI) |
‐0.32 [‐0.63, ‐0.02] |
2.2 Bronchial thermoplasty versus sham bronchoscopies |
1 |
288 |
Mean Difference (IV, Random, 95% CI) |
‐0.01 [‐0.23, 0.21] |
3 Participants admitted to hospital because of respiratory adverse events (treatment period) |
3 |
429 |
Risk Ratio (M‐H, Random, 95% CI) |
3.50 [1.26, 9.68] |
4 Participants admitted to hospital because of respiratory adverse events (post‐treatment period) |
3 |
429 |
Risk Ratio (M‐H, Random, 95% CI) |
1.12 [0.44, 2.85] |
5 Use of rescue medication at 12 months of follow‐up (short‐acting bronchodilator puffs per week) |
3 |
429 |
Mean Difference (IV, Random, 95% CI) |
‐0.68 [‐3.63, 2.28] |
5.1 Bronchial thermoplasty versus medical management |
2 |
141 |
Mean Difference (IV, Random, 95% CI) |
‐2.65 [‐11.24, 5.95] |
5.2 Bronchial thermoplasty versus sham bronchoscopies |
1 |
288 |
Mean Difference (IV, Random, 95% CI) |
‐0.10 [‐3.38, 3.18] |